drugset / Trial / NCT05217719
Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients
Phase 4
Unknown
178 enrolled
Nanfang Hospital, Southern Medical University
Shenzhen Hospital of Southern Medical University · collabThe Second People's Hospital of GuangDong Province · collabThe Third Affiliated Hospital of Southern Medical University · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The incidence of thrombocytopenia in ICU patients with severe illness ranged from 8.3% to 67.6%, and ranged from 14% to 44% during ICU treatment.Severe patients with thrombocytopenia also have significantly increased bleeding events and blood transfusions, and even a significantly increased risk of death.This study examines whether elevated platelets benefit patients with pneumonia
Timeline
- Start
- 2022-02
- Primary completion
- 2023-08
- Completion
- 2023-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | recombinant human thrombopoietin | Protein / enzyme biologic | 15000 iu | Subcutaneous |